Content :
Events 2006
December 5, 2006 Acomplia® (rimonabant) – SERENADE study clinical dataThe SERENADE study clinical data were reviewed at 3.30 p.m (Paris time) by Mr. Douglas Greene, Senior Vice President and Chief Medical Officer, sanofi-aventis United States. 
October 31, 2006 Third Quarter 2006 Sales and EarningsThe Third Quarter 2006 Sales and Earnings were presented in Paris on October 31, 2006. Audio webcast of the conference call given by Mr. Hanspeter Spek, Executive Vice President Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President CFO. 
September 28, 2006 Sanofi Pasteur MSD Conference Call about Gardasil®
Audio webcast held on September 28, 2006 at 2.30 p.m (CET) in English and at 4.00 p.m. (CET) in French 
August 2, 2006 First Half 2006 Sales and EarningsSanofi-aventis sales and earnings figures for the first half of 2006 were presented in Paris on August 2, 2006. Audio webcast of the conference call with financial analysts, investors and journalists given by Hanspeter Spek (Executive Vice President Pharmaceutical Operations) and Jean-Claude Leroy (Executive Vice President, CFO). 
May 31, 2006 General Meeting 2006The sanofi-aventis General Meeting of shareholders was on May 31, 2006 in Paris. 
May 5, 2006 First Quarter 2006 Sales and EarningsSanofi-aventis sales and earnings figures for the first quarter of 2006 were presented in Paris on May 5, 2006. Audio webcast of the conference call with financial analysts, investors and journalists given by Hanspeter Spek (Executive Vice President Pharmaceutical Operations) and Jean-Claude Leroy (Executive Vice President, CFO). 
March 22, 2006 2005 Results - New York Information MeetingFull-Year 2005 results are reviewed in New York at 1.00 p.m (EST) by Mr. Jean-François Dehecq, Chairman and Chief Executive Officer, Mr. Gérard Le Fur, Senior Executive Vice President and Executive Vice President Science and Medical Affairs, Mr. Hanspeter Spek, Executive Vice President Pharmaceutical Operations and Mr. Jean-Claude Leroy, Senior Vice President CFO. 
February 24, 2006 2005 Full-Year Results - Analysts / Investors meeting in ParisThe live video webcasts on the Full-Year 2005 results presented on February 24, 2006 at 9 a.m (CET) in French with simultaneous English translation and at 3 p.m (CET) in English are available. Both presentations are followed by Q&A sessions. 
January 30, 2006 4th Quarter and Full-Year 2005 salesThe 4th Quarter and Full-Year 2005 sales are reviewed by Mr. Hanspeter Spek, Executive Vice President Pharmaceutical Operations and Mr. Jean-Claude Leroy, Senior Vice President CFO. The presentation is followed by a Q&A session. |
Slots : |
